Product image of Memantina Pharma Combix (Memantine Hydrochloride) supplied by GNH India

Memantina Pharma Combix

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantina Pharma Combix (Memantine Hydrochloride)

Memantine, the active ingredient in Memantina Pharma Combix, is a NMDA receptor antagonist presented as an unknown/unknown for oral use. It treats moderate to severe Alzheimer's disease in adults by modulating glutamatergic neurotransmission and reducing neuronal excitotoxicity.

GNH India supplies Memantina Pharma Combix as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Laboratorios Combix, S.L.U.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantine is indicated for the treatment of Alzheimer's disease, acting on the glutamatergic pathway to improve symptomatic outcomes.

  • Moderate Alzheimer's disease: helps maintain cognition and daily activities.
  • Severe Alzheimer's disease: may improve functional abilities.
  • Overall Alzheimer's disease: supports symptomatic management of cognitive decline.

How It Works

  • Memantine hydrochloride acts as a non‑competitive antagonist at the NMDA‑type glutamate receptor. By binding to the receptor-associated ion channel, it blocks excessive calcium influx caused by overstimulation, thereby reducing excitotoxic neuronal damage while preserving normal synaptic transmission essential for learning and memory.

Side Effects

Memantine is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Dizziness: sensation of light‑headedness or unsteadiness.
  • Headache: mild to moderate cranial pain.
  • Constipation: reduced bowel motility.
  • Confusion: transient mental clouding.
  • Fatigue: feeling unusually tired.
  • Nausea: upset stomach or urge to vomit.

Serious or Rare Side Effects

  • Seizures: convulsive episodes requiring immediate medical attention.
  • Hallucinations: visual or auditory disturbances.
  • Allergic reactions: rash, itching, swelling, or anaphylaxis.
  • Hepatic dysfunction: abnormal liver enzymes or jaundice.
  • Cardiac arrhythmias: irregular heart rhythm.
  • Stevens‑Johnson syndrome: severe skin blistering and mucosal involvement.

Precautions & Warnings

When prescribing Memantina Pharma Combix, consider the following safety measures.

  • Renal impairment: monitor renal function and adjust therapy as needed.
  • History of seizures: use with caution and observe for increased seizure activity.
  • Cardiovascular disease: assess blood pressure and heart rate regularly.
  • Psychiatric conditions: watch for worsening agitation or psychosis.
  • Concomitant medications: review for potential drug interactions.
  • Store at ambient temperature: keep in the original pack, protect from moisture and direct sunlight.

Avoid Interactions

Memantine may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid)

  • Amantadine: additive central nervous system effects may increase toxicity.
  • Ketamine: combined NMDA antagonism can heighten neurotoxicity.
  • Other NMDA antagonists: concurrent use may lead to excessive receptor blockade.

Moderate Interactions (Monitor Closely)

  • Anticholinergics: may diminish memantine's cognitive benefits.
  • Diuretics: electrolyte shifts could affect neuronal stability.
  • CNS depressants: increased sedation or dizziness may occur.

Frequently Asked Questions

Memantina Pharma Combix contains memantine hydrochloride and is used to treat moderate to severe Alzheimer's disease. It helps improve cognition, memory, and daily functioning by modulating glutamate activity in the brain.

Memantine acts as a non‑competitive antagonist of NMDA receptors. By blocking excessive calcium influx caused by overstimulation of these receptors, it reduces excitotoxic neuronal damage while preserving normal synaptic transmission needed for learning and memory.

The specific dose of Memantina Pharma Combix is determined by the prescribing clinician based on the patient’s condition, age, renal function, and other clinical factors. The prescriber will set the appropriate dosage regimen.

Safety data for memantine in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Memantine belongs to the NMDA receptor antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both improve symptoms, memantine targets glutamate‑mediated excitotoxicity, making it especially useful in moderate to severe stages where cholinergic agents alone may be insufficient.

Store the product at ambient temperature, below 25 °C. Keep it in the original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Memantina Pharma Combix is taken orally, usually with or without food, as directed by the prescribing physician. The tablet (or other oral form) should be swallowed whole with a glass of water.

Serious risks include seizures, severe allergic reactions (including anaphylaxis), hepatic dysfunction, cardiac arrhythmias, and rare skin conditions such as Stevens‑Johnson syndrome. Patients should seek immediate medical attention if any of these occur.

Memantina Pharma Combix should be avoided in patients with known hypersensitivity to memantine or any excipients, and used with caution in individuals with severe renal impairment, uncontrolled seizures, or significant cardiac disease. The prescriber will assess suitability on a case‑by‑case basis.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT